nextgen

Marathon Nextgen Realty Ltd Achieves Record 33% PAT Margin in Q3 FY25Marathon Nextgen Realty Ltd Achieves Record 33% PAT Margin in Q3 FY25

Marathon Nextgen Realty Ltd Achieves Record 33% PAT Margin in Q3 FY25

MUMBAI, India , Feb. 14, 2025 /PRNewswire/ -- Marathon Nextgen Realty Ltd. (BSE: 503101) (NSE: MARATHON) (ISIN: INE182D01020), one of Mumbai's leading…

2 months ago
NEXTGEN DIGITAL ANNOUNCES UPSIZE OF NON-BROKERED PRIVATE PLACEMENT TO $1.2 MILLION & PURCHASE OF XRP COINSNEXTGEN DIGITAL ANNOUNCES UPSIZE OF NON-BROKERED PRIVATE PLACEMENT TO $1.2 MILLION & PURCHASE OF XRP COINS

NEXTGEN DIGITAL ANNOUNCES UPSIZE OF NON-BROKERED PRIVATE PLACEMENT TO $1.2 MILLION & PURCHASE OF XRP COINS

– NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – January 29, 2025 02:00 ET  |…

3 months ago
NEXTGEN DIGITAL PLATFORMS ENTERS INTO LOI TO ACQUIRE CRYPTO ASSETSNEXTGEN DIGITAL PLATFORMS ENTERS INTO LOI TO ACQUIRE CRYPTO ASSETS

NEXTGEN DIGITAL PLATFORMS ENTERS INTO LOI TO ACQUIRE CRYPTO ASSETS

NextGen expands into the cryptocurrency market, acquiring approximately 10,000 Solana coins (SOL) January 27, 2025 02:00 ET  | Source: NextGen…

3 months ago
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-FluDIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing…

3 months ago
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-FluDIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing…

3 months ago
DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-FluDIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

DIOSynVax Announces a new Advisory Board as it drives the clinical development of its NextGen Influenza Vaccines including Bird-Flu

CAMBRIDGE, England and SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- DIOSynVax, a clinical-stage biotechnology company at the forefront of developing…

3 months ago
NextGen Digital Provides Business Progress Updates and Announces Strategic ExpansionNextGen Digital Provides Business Progress Updates and Announces Strategic Expansion

NextGen Digital Provides Business Progress Updates and Announces Strategic Expansion

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – December 20, 2024 21:00 ET  |…

4 months ago
NextGen Digital Provides Business Progress Updates and Announces Strategic ExpansionNextGen Digital Provides Business Progress Updates and Announces Strategic Expansion

NextGen Digital Provides Business Progress Updates and Announces Strategic Expansion

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES – December 20, 2024 21:00 ET  |…

4 months ago
Marathon Nextgen Realty Limited Quarterly Earnings Release | Q2 FY25Marathon Nextgen Realty Limited Quarterly Earnings Release | Q2 FY25

Marathon Nextgen Realty Limited Quarterly Earnings Release | Q2 FY25

MUMBAI, India, Nov. 19, 2024 /PRNewswire/ -- Marathon Nextgen Realty Ltd. (BSE: 503101) (NSE: MARATHON) (ISIN: INE182D01020), one of the leading…

5 months ago